Information Journal Paper
APA:
Copy. (2019). SGLT-2 inhibitors in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review. WORLD JOURNAL OF DIABETES, 10(2), 0-0. SID. https://sid.ir/paper/693495/en
Vancouver:
Copy. SGLT-2 inhibitors in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review. WORLD JOURNAL OF DIABETES[Internet]. 2019;10(2):0-0. Available from: https://sid.ir/paper/693495/en
IEEE:
Copy, “SGLT-2 inhibitors in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review,” WORLD JOURNAL OF DIABETES, vol. 10, no. 2, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/693495/en